A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa)

Journal of Immunological Methods

Volumn 376, Issue 1-2, 2012, Pages 132-138

  Papageorgiou, Peter C ^a,b   Yeo, Erik L ^b   Backx, Peter H ^a,b,c   Floras, John S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

FXIIa; Activated coagulation Factor XII; FXIIa; Hageman fragment factor

Indexed keywords

BLOOD CLOTTING FACTOR 12A; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; HUMAN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FACTOR XIIA; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RATS;

RATTUS;

EID: 84856516814     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.01.002     Document Type: Article

References (34)

1. Amfilochiadis A.A., Papageorgiou P.C., Kogan N., Boomsma F., Osmond D.H. Role of bradykinin B2-receptor in the sympathoadrenal effects of 'New Pressor Protein' related to human blood coagulation factor XII fragment. J. Hypertens. 2004, 22:1173-1181.
2. Amfilochiadis A.A., Backx P.H., Floras J.S. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins. J. Hypertens. 2008, 26:61-69.
3. Bordeaux J., Welsh A., Agarwal S., Killiam E., Baquero M., Hanna J., Anagnostou V., Rimm D. Antibody validation. Biotechniques 2010, 48:197-209.
4. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 1981, 112:195-203.
5. Chong G.L., Reeck G.R. Interaction of trypsin, beta-factor XIIa, and plasma kallikrein with a trypsin inhibitor isolated from barley seeds: a comparison with the corn inhibitor of activated Hageman factor. Thromb. Res. 1987, 48:211-221.
6. Colhoun H.M., Zito F., Norman Chan N., Rubens M.B., Fuller J.H., Humphries S.E. Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis 2002, 163:363-369.
7. Coppola R., Cristilli P., Cugno M., Ariens R.A., Mari D., Mannucci P.M. Measurement of activated factor XII in health and disease. Blood Coagul. Fibrinolysis 1996, 7:530-535.
8. Czendlik C., Lammle B., Duckert F. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Thromb. Haemost. 1985, 53:242-244.
9. Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 1964, 145:1310-1312.
10. Esnouf M.P., Burgess A.I., Dodds A.W., Sarphie A.F., Miller G.J. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor. Thromb. Haemost. 2000, 83:874-881.
11. Ford R.P., Esnouf M.P., Burgess A.I., Sarphie A. An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma. J. Immunoassay 1996, 17:119-131.
12. Gao B., Esnouf M.P. Multiple interactive residues of recognition: elucidation of discontinuous epitopes with linear peptides. J. Immunol. 1996, 157:183-188.
13. Gao B., Esnouf M.P. Elucidation of the core residues of an epitope using membrane-based combinatorial peptide libraries. J. Biol. Chem. 1996, 271:24634-24638.
14. Hazegh-Azam M., Kim S.S., Masoud S., Andersson L., White F., Johnson L., Muthukrishnan S., Reeck G. The corn inhibitor of activated Hageman factor: purification and properties of two recombinant forms of the protein. Protein Expr. Purif. 1998, 13:143-149.
15. Ishii K., Oguchi S., Murata M., Mitsuyoshi Y., Takeshita E., Ito D., Tanahashi N., Fukuuchi Y., Oosumi K., Matsumoto K., Kitajima M., Yamamoto M., Watanabe G., Ikeda Y., Watanabe K. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects. Blood Coagul. Fibrinolysis 2000, 11:277-284.
16. Ishikawa E., Imagawa M., Hashida S., Yoshitake S., Hamaguchi Y., Ueno T. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J. Immunoassay 1983, 4:209-327.
17. Kleinschnitz C., Stoll G., Bendszus M., Schuh K., Pauer H.U., Burfeind P., Renne C., Gailani D., Nieswandt B., Renne T. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 2006, 203:513-518.
18. Lowe G.D., Rumley A., McMahon A.D., Ford I., O'Reilly D.S., Packard C.J. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1529-1534.
19. Matsuo T., Koide M., Kario K., Suzuki S., Matsuo M. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Haemostasis 1997, 27:163-167.
20. Mavrogiannis L., Kariyawasam K.P., Osmond D.H. Potent blood pressure raising effects of activated coagulation factor XII. Can. J. Physiol. Pharmacol. 1997, 75:1398-1403.
21. Munakata M., Komiyama Y., Mori T., Okuda K., Murakami T., Masuda M., Egawa H., Takahashi H. Evaluation of the factor XIIa assay kit. Rinsho Byori 1996, 44:883-888.
22. Nevard C.H., Jurd K.M., Lane D.A., Philippou H., Haycock G.B., Hunt B.J. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb. Haemost. 1997, 78:1450-1455.
23. Osmond D.H., Mavrogiannis L., Cotter B.R. Potent 'new pressor protein' related to coagulation factor XII is potentiated by inhibition of angiotensin converting enzyme. J. Hypertens. 1998, 16:311-320.
24. Papageorgiou P.C., Pourdjabbar A., Amfilochiadis A.A., Diamandis E.P., Boomsma F., Osmond D.H. Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H837-H846.
25. Papageorgiou P.C., Simos D., Boomsma F., Rojkjaer R., Osmond D.H. Angiotensin converting enzyme-regulated, noncholinergic sympathoadrenal catecholamine release mediates the cardiovascular actions of human 'new pressor protein' related to coagulation beta-factor XIIa. Can. J. Cardiol. 2009, 25:e100-e108.
26. Pearl R.J., Papageorgiou P.C., Goldman M., Amfilochiadis A.A., Boomsma F., Rojkjaer R., Geary D., Osmond D.H. Possible role of new pressor protein in hypertensive anephric hemodialysis patients. Pediatr. Nephrol. 2003, 18:1025-1031.
27. Peng S., Zhao M. Methods and applications of blood pressure-related assays: human plasma new pressor protein assay. Pharmaceutical Bioassays: Methods and Applications 2009, 87-89. John Wiley & Sons, Hoboken, New Jersey. M. Zhao (Ed.).
28. Pritchard, D. (2008). Forms of Factor XIIa. In: Patent Application Publication US 2008/0274477 A1, United States.
29. Ratnoff O.D., Colopy J.E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J. Clin. Invest. 1955, 34:602-613.
30. Renne T., Pozgajova M., Gruner S., Schuh K., Pauer H.U., Burfeind P., Gailani D., Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 2005, 202:271-281.
31. Saito H. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays. Adv. Exp. Med. Biol. 1979, 120A:165-172.
32. Saito H., Ratnoff O.D., Pensky J. Radioimmunoassay of human Hageman factor (factor XII). J. Lab. Clin. Med. 1976, 88:506-514.
33. Saito H., Hamilton S.M., Tavill A.S., Goodnough L.T., Louis L., Angell A. Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver. J. Clin. Invest. 1983, 72:948-954.
34. Simos D., Boomsma F., Osmond D.H. Human coagulation factor XII-related "new pressor protein": role of PACAP in its cardiovascular and sympathoadrenal effects. Can. J. Cardiol. 2002, 18:1093-1103.